Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care

BACKGROUND: Hotspot mutations of the oncogenes BRAF and NRAS are the most common genetic alterations in cutaneous melanoma. Specific inhibitors of BRAF and MEK have shown significant survival benefits in large phase III trials. However, the prognostic significance of BRAF and NRAS mutations outside...

Descripción completa

Detalles Bibliográficos
Autores principales: Heppt, Markus V., Siepmann, Timo, Engel, Jutta, Schubert-Fritschle, Gabriele, Eckel, Renate, Mirlach, Laura, Kirchner, Thomas, Jung, Andreas, Gesierich, Anja, Ruzicka, Thomas, Flaig, Michael J., Berking, Carola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553744/
https://www.ncbi.nlm.nih.gov/pubmed/28797232
http://dx.doi.org/10.1186/s12885-017-3529-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553744/
https://www.ncbi.nlm.nih.gov/pubmed/28797232
http://dx.doi.org/10.1186/s12885-017-3529-5

Ejemplares similares